Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Finding A New Role For Yervoy

Executive Summary

Academics question whether Yervoy would enjoy broader use at a lower dose in a combination with PD-1 or in a sequential protocol to minimize severe side effects and costs, and boost use in the community setting.